Research News and Research

RSS

PCF funds 10 new Challenge Awards for prostate cancer research

The Prostate Cancer Foundation today announced that it has funded 10 new Challenge Awards for accelerating scientific discovery and new treatments for prostate cancer patients.

5 Aug 2011

Roadmap to overcome obstacles for using induced pluripotent stem cells

The possibility of developing stem cells from a patient's own skin and using them to treat conditions as diverse as Parkinson's disease, Alzheimer's disease and cancer has generated tremendous excitement in the stem cell research community in recent years. Such therapies would avoid the controversial need for using stem cells derived from human embryos, and in theory, also bypass immunological problems inherent in using cells from one person to treat another.

5 Aug 2011

Study: Poorly controlled asthma doubles healthcare costs linked with disease

Poorly controlled asthma more than doubles healthcare costs associated with the disease and threatens educational achievement through a dramatic increase in school absence, according to researchers at National Jewish Health.

5 Aug 2011

Viewpoints: 'Real' Medicare cuts?; HIV/AIDS prevention push; contraceptive coverage

Well, not really. A primer on the debt deal's health-care bookkeeping. All politicians—but these days especially Democrats—like to pretend they'll pay providers somewhat less in the future, despite knowing that is unlikely to happen in practice. Medicare's prospective payments are low enough that further reductions may jeopardize access to care and in many cases threaten the viability of hospitals and physician practices.

5 Aug 2011

Virginia Tech student receives prestigious award for cellular signaling receptor study linked to diabetes, obesity

Stephanie Nicole "Nikki" Lewis, a graduate student in the interdisciplinary doctoral program in genetics, bioinformatics, and computational biology at Virginia Tech, has been awarded the prestigious Ruth L. Kirschstein National Research Service Award for Predoctoral Research through the National Institutes of Health for her study of a cellular signaling receptor that is associated with chronic inflammatory diseases such as diabetes, obesity, and inflammatory bowel disease.

5 Aug 2011

WSU receives $3M NIH grant for student development program

The National Institute of General Medical Sciences of the National Institutes of Health (NIH) has announced a five-year grant of more than $3 million to support the Wayne State University Initiative for Maximizing Student Development (IMSD) program.

5 Aug 2011

Glove with special fingertip can improve wearer's sense of touch

A little vibration can be a good thing for people who need a sensitive touch. Researchers at the Georgia Institute of Technology have developed a glove with a special fingertip designed to improve the wearer's sense of touch. Applying a small vibration to the side of the fingertip improves tactile sensitivity and motor performance, according to their research results.

5 Aug 2011

Scientists develop Instant Corn Soy Blend for young children

U.S. Department of Agriculture (USDA) scientists have developed a fully cooked food-aid product called Instant Corn Soy Blend that supplements meals, particularly for young children.

5 Aug 2011

New doc-fix plan links payment to quality

Republican staff on the Energy and Commerce Committee are considering a proposal to address the problem of looming cuts to Medicare physician payments by implementing a pay-for-performance system, according to lobbying sources.

5 Aug 2011

Researchers identify genes that play a key role in pain perception

By working with individuals suffering from a severe disorder that causes sensory neurons to degenerate, researchers at the University of Montreal Hospital and CHU Sainte-Justine Hospital have discovered how a specific genetic mutation causes their patients' condition, which in turn has revealed more information about the mechanisms in our bodies which enable us to sense pain.

5 Aug 2011

Daily text messages to health workers improve proper malaria treatment administration, study shows

"Sending daily text message reminders to health workers can mean nearly 25 percent more children are properly treated for malaria, according to the results of a six-month trial conducted in Kenya" published Thursday in the Lancet, Reuters reports.

5 Aug 2011

Abiomed first quarter fiscal 2012 revenue up 25% to $27.4 million

Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2012 revenue of $27.4 million, up 25% compared to revenue of $22.0 million in the same period of fiscal 2011.

4 Aug 2011

ArQule second quarter net loss increases to $10,804,000

ArQule, Inc. today announced its financial results for the second quarter of 2011.

4 Aug 2011

Hundreds of parents in Nigerian state refusing polio vaccinations for children

Hundreds of parents "are defying threats of jail time by refusing polio vaccines for their children in a high-risk northern Nigerian state," according to Muhammad Abdu Zango, Kano state coordinator of Journalists Against Polio, the Associated Press/Seattle Times reports.

4 Aug 2011

MOCON second quarter net sales increase 24% to $9,082,000

MOCON, Inc. today reported its operating results for the second quarter ended June 30, 2011.

4 Aug 2011

Valeant second quarter total revenue increases to record $609.4 million

Valeant Pharmaceuticals International, Inc. announces second quarter financial results for 2011.

4 Aug 2011

First Edition: August 4, 2011

In today's news, reports about how lawmakers, lobbyists are lining up for the next phase of the deficit deal.

4 Aug 2011

Dyax initiates ecallantide Phase 2 trial for ACE inhibitor-induced angioedema

Dyax Corp. announced today treatment of the first patient in a Phase 2 trial evaluating the efficacy and safety of ecallantide, a potent, selective, reversible inhibitor of plasma kallikrein, for acute treatment of angiotensin converting enzyme (ACE) inhibitor-induced angioedema.

4 Aug 2011

Palatin confirms initiation of AZD2820 Phase 1 trial in obesity

Palatin Technologies, Inc. confirmed today the commencement of a Phase 1 clinical trial of AZD2820, a subcutaneously-administered peptide melanocortin receptor partial agonist, under development as a single-agent therapy for the treatment of obesity.

4 Aug 2011

RNAi screen identifies Brd4 as a therapeutic target for acute myeloid leukemia

Scientists at Cold Spring Harbor Laboratory (CSHL) and five other institutions have used an unconventional approach to cancer drug discovery to identify a new potential treatment for acute myeloid leukemia.

4 Aug 2011